Works matching AU De Zwart, Loeckie

Results: 17

Comparison of five in vitro digestion models to in vivo experimental results: Lead bioaccessibility in the human gastrointestinal tract.

Published in:

Journal of Environmental Science & Health. Part A. Toxic/Hazardous Substances & Environmental Engineering, 2007, v. 42, n. 9, p. 1203, doi. 10.1080/10934520701434919

By:

Van de Wiele, Tom R.;
Oomen, Agnes G.;
Wragg, Joanna;
Cave, Mark;
Minekus, Mans;
Hack, Alfons;
Cornelis, Christa;
Rompelberg, Cathy J.M.;
De Zwart, Loeckie L.;
Klinck, Ben;
Van Wijnen, Joop;
Verstraete, Willy;
Sips, Adriënne J.A.M.

Publication type:

Article

Effect of Erdafitinib on the Pharmacokinetics of Midazolam and Metformin in Patients With Advanced Solid Tumors Harboring FGFR Gene Alterations.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 10, p. 1164, doi. 10.1002/cpdd.1445

By:

Zhu, Wei;
Baig, Mahadi;
Naini, Vahid;
De Meulder, Marc;
Akapame, Sydney;
De Zwart, Loeckie;
Haddish‐Berhane, Nahor;
Triantos, Spyros

Publication type:

Article

Effect of Carbamazepine on the Pharmacokinetics of Erdafitinib in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 8, p. 852, doi. 10.1002/cpdd.1412

By:

Jaiprasart, Pharavee;
Hellemans, Peter;
Jiao, Juhui James;
Dosne, Anne‐Gaëlle;
De Meulder, Marc;
De Zwart, Loeckie;
Brees, Laurane;
Zhu, Wei

Publication type:

Article

Correction to: Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects.

Published in:

2020

By:

Vandenbossche, Joris;
Jessner, Wolfgang;
van den Boer, Maarten;
Biewenga, Jeike;
Berke, Jan Martin;
Talloen, Willem;
De Zwart, Loeckie;
Snoeys, Jan;
Vandyck, Koen;
Fry, John;
Yogaratnam, Jeysen

Publication type:

corrected article

Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects.

Published in:

2019

By:

Vandenbossche, Joris;
Jessner, Wolfgang;
van den Boer, Maarten;
Biewenga, Jeike;
Berke, Jan Martin;
Talloen, Willem;
De Zwart, Loeckie;
Snoeys, Jan;
Yogaratnam, Jeysen

Publication type:

journal article

Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 403, doi. 10.1002/cpt.3477

By:

Reddy, Micaela B.;
Cabalu, Tamara D.;
de Zwart, Loeckie;
Ramsden, Diane;
Dowty, Martin E.;
Taskar, Kunal S.;
Badée, Justine;
Bolleddula, Jayaprakasam;
Boulu, Laurent;
Fu, Qiang;
Kotsuma, Masakatsu;
Leblanc, Alix F.;
Lewis, Gareth;
Liang, Guiqing;
Parrott, Neil;
Pilla Reddy, Venkatesh;
Prakash, Chandra;
Shah, Kushal;
Umehara, Kenichi;
Mukherjee, Dwaipayan

Publication type:

Article

Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 4, p. 770, doi. 10.1002/cpt.2503

By:

Hariparsad, Niresh;
Ramsden, Diane;
Taskar, Kunal;
Badée, Justine;
Venkatakrishnan, Karthik;
Reddy, Micaela B.;
Cabalu, Tamara;
Mukherjee, Dwaipayan;
Rehmel, Jessica;
Bolleddula, Jayaprakasam;
Emami Riedmaier, Arian;
Prakash, Chandra;
Chanteux, Hugues;
Mao, Jialin;
Umehara, Kenichi;
Shah, Kushal;
De Zwart, Loeckie;
Dowty, Martin;
Kotsuma, Masakatsu;
Li, Mengyao

Publication type:

Article

A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies.

Published in:

Leukemia & Lymphoma, 2018, v. 59, n. 12, p. 2888, doi. 10.1080/10428194.2018.1460474

By:

de Jong, Jan;
Hellemans, Peter;
De Wilde, Severijn;
Patricia, Daniel;
Masterson, Tara;
Manikhas, Georgii;
Myasnikov, Alexander;
Osmanov, Dzhelil;
Córdoba, Raúl;
Panizo, Carlos;
de Zwart, Loeckie;
Snoeys, Jan;
Chauhan, Vijay;
Jiao, James;
Sukbuntherng, Juthamas;
Ouellet, Daniele

Publication type:

Article

Excretion of multiple urinary biomarkers for radical induced damage in rats treated with three different nephrotoxic compounds.

Published in:

Biomarkers, 1998, v. 3, n. 4/5, p. 347, doi. 10.1080/135475098231156

By:

Zwart, Loeckie L. De;
Hermanns, Ralph C. A.;
Meerman, John H. N.;
Commandeur, Jan N. M.;
Ink, Paul J. M . Salem;
Vermeulen, Nico P. E.

Publication type:

Article

Evaluation of Drug–Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model

Published in:

Targeted Oncology, 2024, v. 19, n. 6, p. 965, doi. 10.1007/s11523-024-01093-6

By:

Willemin, Marie-Emilie;
Gong, Jue;
Hilder, Brandi W.;
Masterson, Tara;
Tolbert, Jaszianne;
Renaud, Thomas;
Heuck, Christoph;
Kane, Colleen;
De Zwart, Loeckie;
Girgis, Suzette;
Ma, Xuewen;
Ouellet, Daniele

Publication type:

Article

Prediction of Drug-Drug Interactions After Esketamine Intranasal Administration Using a Physiologically Based Pharmacokinetic Model.

Published in:

2022

By:

Willemin, Marie-Emilie;
Zannikos, Peter;
Mannens, Geert;
de Zwart, Loeckie;
Snoeys, Jan

Publication type:

journal article

Pharmacokinetic Drug–Drug Interaction of Apalutamide, Part 2: Investigating Interaction Potential Using a Physiologically Based Pharmacokinetic Model.

Published in:

Clinical Pharmacokinetics, 2020, v. 59, n. 9, p. 1149, doi. 10.1007/s40262-020-00881-3

By:

Van den Bergh, An;
Snoeys, Jan;
De Zwart, Loeckie;
Ward, Peter;
Lopez-Gitlitz, Angela;
Ouellet, Daniele;
Monshouwer, Mario;
Chien, Caly

Publication type:

Article

Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1117, doi. 10.1002/psp4.13144

By:

Willemin, Marie‐Emilie;
Wang Lin, Shun Xin;
De Zwart, Loeckie;
Wu, Liviawati S.;
Miao, Xin;
Verona, Raluca;
Banerjee, Arnob;
Liu, Baolian;
Kobos, Rachel;
Qi, Ming;
Ouellet, Daniele;
Goldberg, Jenna D.;
Girgis, Suzette

Publication type:

Article

Physiologically‐based pharmacokinetic modeling for primary metabolites of CYP3A and P‐glycoprotein inhibitors in drug–drug interactions: Should we assume the free drug hypothesis?

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 1, p. 8, doi. 10.1002/psp4.12879

By:

Yamazaki, Shinji;
Evers, Raymond;
De Zwart, Loeckie

Publication type:

Article

Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 10, p. 1394, doi. 10.1002/psp4.12860

By:

Yamazaki, Shinji;
Evers, Raymond;
De Zwart, Loeckie

Publication type:

Article

Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 1, p. 55, doi. 10.1002/psp4.12733

By:

Yamazaki, Shinji;
Evers, Raymond;
De Zwart, Loeckie

Publication type:

Article

Prediction of the drug–drug interaction potential of the α1‐acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 9, p. 1107, doi. 10.1002/psp4.12682

By:

De Zwart, Loeckie;
Snoeys, Jan;
Jacobs, Frank;
Li, Lilian Y.;
Poggesi, Italo;
Verboven, Peter;
Goris, Ivo;
Scheers, Ellen;
Wynant, Inneke;
Monshouwer, Mario;
Mamidi, Rao N. V. S.

Publication type:

Article